deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT04578873

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single- and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Oral QPX7831 in Healthy Adult Subjects

Sponsor: Biomedical Advanced Research and Development Authority

Conditions Bacterial Infections
Interventions QPX7831 placebo comparator
Updated 11 times since 2020 Last updated: Oct 6, 2022 Started: Apr 13, 2021 Primary completion: Aug 30, 2022 Completion: Aug 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Bacterial Infections and is currently completed. Biomedical Advanced Research and Development Authority leads this study, which shows 11 recorded versions since 2021 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotNot Yet Recruiting~Apr 2021 – ~May 2021 · 30 days · monthly snapshotRecruiting~May 2021 – ~Sep 2021 · 4 months · monthly snapshotRecruiting~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshotRecruiting~Mar 2022 – ~May 2022 · 2 months · monthly snapshotRecruiting~May 2022 – ~Sep 2022 · 4 months · monthly snapshotRecruiting~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshotCompleted~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE1

  4. Sep 2022 — Nov 2022 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  5. May 2022 — Sep 2022 [monthly]

    Recruiting PHASE1

▶ Show 6 earlier versions

  1. Mar 2022 — May 2022 [monthly]

    Recruiting PHASE1

  2. Sep 2021 — Mar 2022 [monthly]

    Recruiting PHASE1

  3. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

  4. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  5. Jan 2021 — Apr 2021 [monthly]

    Not Yet Recruiting PHASE1

  6. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Biomedical Advanced Research and Development Authority
  • Qpex Biopharma, Inc.
Data source: Qpex Biopharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations